Immunotherapeutic Drugs Market 2019, Global Industry Analysis, Size, Share, Growth, Trends and Forecast – 2024

A New Market Study, titled “Immunotherapeutic Drugs Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.

PUNE, MARKETERSMEDIA, INDIA, September 3, 2019 /EINPresswire.com/ — Summary

A New Market Study, titled “Immunotherapeutic Drugs Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.

This report provides in depth study of “Immunotherapeutic Drugs Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Immunotherapeutic Drugs Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This market report offers a comprehensive analysis of the global Immunotherapeutic Drugs market. This report focused on Interdental Cleaners market past and present growth globally. Global research on Global Interdental Cleaners Industry presents a market overview, product details, classification, market concentration, and maturity study. The market value and growth rate from 2019-2025 along with industry size estimates are explained.

Immunotherapy is a cancer treatment that enhances the body's natural defenses against cancer-fighting tissues.In this treatment, substances made in the body or laboratory are used to improve or restore immune system function.The drugs used in this treatment are called immunotherapeutics.Immunotherapy drugs are designed to warn the immune system about mutated cells, so it can easily find and destroy them.

This report focuses on the global Immunotherapeutic Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immunotherapeutic Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Roche
Merck
Novartis
Johnson & Johnson
GlaxoSmithKline
AbbVie
ELI Lilly
Amgen
AstraZeneca
Bristol-Mysers Squibb

Request a Free Sample Report @ https://www.wiseguyreports.com/sample-request/4390925-global-immunotherapeutic-drugs-market-size-status-and-forecast-2019-2025

Market segment by Type, the product can be split into
Monoclonal Antibody
Vaccines
Checkpoint Inhibitor
Interferon

Market segment by Application, split into
Hospitals
Clinics
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

At Any Query @ https://www.wiseguyreports.com/enquiry/4390925-global-immunotherapeutic-drugs-market-size-status-and-forecast-2019-2025

Major Key Points in Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Immunotherapeutic Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Monoclonal Antibody
1.4.3 Vaccines
1.4.4 Checkpoint Inhibitor
1.4.5 Interferon
1.5 Market by Application
1.5.1 Global Immunotherapeutic Drugs Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Immunotherapeutic Drugs Market Size
2.2 Immunotherapeutic Drugs Growth Trends by Regions
2.2.1 Immunotherapeutic Drugs Market Size by Regions (2019-2025)
2.2.2 Immunotherapeutic Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

….

12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Immunotherapeutic Drugs Introduction
12.1.4 Roche Revenue in Immunotherapeutic Drugs Business (2014-2019))
12.1.5 Roche Recent Development
12.2 Merck
12.2.1 Merck Company Details
12.2.2 Company Description and Business Overview
12.2.3 Immunotherapeutic Drugs Introduction
12.2.4 Merck Revenue in Immunotherapeutic Drugs Business (2014-2019)
12.2.5 Merck Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Immunotherapeutic Drugs Introduction
12.3.4 Novartis Revenue in Immunotherapeutic Drugs Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Immunotherapeutic Drugs Introduction
12.4.4 Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2014-2019)
12.4.5 Johnson & Johnson Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Company Details
12.5.2 Company Description and Business Overview
12.5.3 Immunotherapeutic Drugs Introduction
12.5.4 GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2014-2019)
12.5.5 GlaxoSmithKline Recent Development
12.6 AbbVie
12.6.1 AbbVie Company Details
12.6.2 Company Description and Business Overview
12.6.3 Immunotherapeutic Drugs Introduction
12.6.4 AbbVie Revenue in Immunotherapeutic Drugs Business (2014-2019)
12.6.5 AbbVie Recent Development
12.7 ELI Lilly
12.7.1 ELI Lilly Company Details
12.7.2 Company Description and Business Overview
12.7.3 Immunotherapeutic Drugs Introduction
12.7.4 ELI Lilly Revenue in Immunotherapeutic Drugs Business (2014-2019)
12.7.5 ELI Lilly Recent Development
12.8 Amgen
12.8.1 Amgen Company Details
12.8.2 Company Description and Business Overview
12.8.3 Immunotherapeutic Drugs Introduction
12.8.4 Amgen Revenue in Immunotherapeutic Drugs Business (2014-2019)
12.8.5 Amgen Recent Development
12.9 AstraZeneca
12.9.1 AstraZeneca Company Details
12.9.2 Company Description and Business Overview
12.9.3 Immunotherapeutic Drugs Introduction
12.9.4 AstraZeneca Revenue in Immunotherapeutic Drugs Business (2014-2019)
12.9.5 AstraZeneca Recent Development
12.10 Bristol-Mysers Squibb
12.10.1 Bristol-Mysers Squibb Company Details
12.10.2 Company Description and Business Overview
12.10.3 Immunotherapeutic Drugs Introduction
12.10.4 Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2014-2019)
12.10.5 Bristol-Mysers Squibb Recent Development

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)

NORAH TRENT
Wise Guy Reports
841-198-5042
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Coffee Pod market study 2019-2025 by key Segmentes like as Capsules, Soft coffee, and Hard coffee

Wiseguyreports.Com Adds “Coffee Pod -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024” To Its Research Database

PUNE, MAHARASHTRA, INDIA, September 3, 2019 /EINPresswire.com/ — Coffee Pod Industry

Description

The global coffee pod market is set to achieve a high valuation in the coming years. Coffee pods contain enough coffee which can be brewed for a single serving. This design eliminates the need of flavors, additives, and portions from large containers. Different styles of coffee pods currently in the market are T-discs, K-cups, and paper coffee pods. Companies have even launched brewing devices which can hold these pods for making coffee.

Large consumption rate of coffee is one of the primary drivers of the global coffee pod market. Benefits of coffee which can keep cancer and type 2 diabetes at bay are likely to facilitate sales of coffee pods. Increasing usage of single servings at households in North America and Europe can bode well for the market growth. Rapid urbanization in developed economies and demand for convenience products by the large working population is predicted to spur market demand. Bans on non-degradable coffee pods in Europe and North America can pose a challenge to the market. However, manufacturers are investing in renewable or recyclable pods to cope up with it.

The major manufacturers covered in this report Nestl (Switzerland), Kraft Foods (U.S.), Luigi Lavazza (Italy), Keurig Green Mountain (U.S.), Coffechino (UK), The J.M. Smucker (U.S.), Ethical Coffee Company (Switzerland), Diedrich Coffee (Australia), Jacobs Douwe Egberts (Netherlands), DD IP Holder (Dunkin' Donuts)

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3291897-global-coffee-pod-market-research-report-2018

The global coffee pod market is segmented by type, application, and region. By type, it is segmented into capsules, soft coffee, and hard coffee. Hard coffee pods can witness a massive demand, while soft coffee pods are witnessing a decline.

By application, it is segmented into departmental stores, supermarkets & hypermarkets, and online stores. The online stores are projected to generate significant revenue for the market due to large sales of coffee pods and associated brewing machines. Partnership with ecommerce brands such as Amazon aided pod manufacturers in attaining high numbers. It can capture a larger market share in the coming years.

Regions covered in the global coffee pod market report include Japan, India, China, Europe, and North America. In Europe, Slovakia and Czech Republic are prime regions which have adopted coffee pods and driven the market growth. This can be credited to the stable economic growth of these countries and high expendable income levels of citizens. Rising interest in special flavors of coffee, entry of private label brands, and adoption of pod brewing systems at local coffee shops, baristas, and cafés are evidence of the large potential of the market in the region.

North America is projected to be one of the biggest regions for the global market. This can be attributed to the massive consumption rate of coffee. In the United States alone, 3 cups are consumed on average by a person on a daily basis reflecting the large potential of coffee pods.

The China and India coffee pod market can thrive due to easy availability of coffee chains and demand for ready-to-drink beverages. Immense demand for non-alcoholic beverages which require coffee as an ingredient can drive the market growth. Supermarkets & hypermarkets have registered higher growth in these countries due to affordable prices and high trustworthiness.

Key players in the global coffee pod market are expanding their lineup of coffee pods and will compete in terms of flavor, taste, and price. Good marketing strategies and tie-ups with coffeehouse chains can assist them in gaining leverage in the market.

Continued…            

Leave a Query @ https://www.wiseguyreports.com/enquiry/3291897-global-coffee-pod-market-research-report-2018

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Dental Regenerative Market 2019, Global Industry Analysis, Size, Share, Growth, Trends and Forecast – 2024

A New Market Study, titled “Dental Regenerative Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.

PUNE, MARKETERSMEDIA, INDIA, September 3, 2019 /EINPresswire.com/ — Summary

A New Market Study, titled “Dental Regenerative Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.

This report provides in depth study of “Dental Regenerative Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Dental Regenerative Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This market report offers a comprehensive analysis of the global Dental Regenerative market. This report focused on Interdental Cleaners market past and present growth globally. Global research on Global Interdental Cleaners Industry presents a market overview, product details, classification, market concentration, and maturity study. The market value and growth rate from 2019-2025 along with industry size estimates are explained.

The emotional connection of natural teeth and the high nature of natural teeth have drawn attention to the development of bioengineered teeth (tooth regeneration).Tooth regeneration is a stem cell-based regenerative medicine procedure that, in the fields of tissue engineering and stem cell biology, replaces damaged or lost teeth by redrawing from autologous stem cells.As a source of new bioengineered teeth, somatic stem cells are collected and reprogrammed into induced pluripotent stem cells that can be placed directly in the dental plate or in a reabsorbable biopolymer in the shape of a new tooth.

This report focuses on the global Dental Regenerative status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dental Regenerative development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Straumann
Dentsply Sirona
3M
Zimmer Biomet
Astellas US Holding
Integra LifeSciences
Datum Dental

Request a Free Sample Report @ https://www.wiseguyreports.com/sample-request/4390914-global-dental-regenerative-market-size-status-and-forecast-2019-2025

Market segment by Type, the product can be split into
Dentin
Dental Pulp
Tooth Enamel

Market segment by Application, split into
Hospitals
Dental Clinics
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Dental Regenerative status, future forecast, growth opportunity, key market and key players.
To present the Dental Regenerative development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Dental Regenerative are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

At Any Query @ https://www.wiseguyreports.com/enquiry/4390914-global-dental-regenerative-market-size-status-and-forecast-2019-2025

Major Key Points in Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Dental Regenerative Market Size Growth Rate by Type (2014-2025)
1.4.2 Dentin
1.4.3 Dental Pulp
1.4.4 Tooth Enamel
1.5 Market by Application
1.5.1 Global Dental Regenerative Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Dental Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Dental Regenerative Market Size
2.2 Dental Regenerative Growth Trends by Regions
2.2.1 Dental Regenerative Market Size by Regions (2019-2025)
2.2.2 Dental Regenerative Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

….

12 International Players Profiles
12.1 Straumann
12.1.1 Straumann Company Details
12.1.2 Company Description and Business Overview
12.1.3 Dental Regenerative Introduction
12.1.4 Straumann Revenue in Dental Regenerative Business (2014-2019))
12.1.5 Straumann Recent Development
12.2 Dentsply Sirona
12.2.1 Dentsply Sirona Company Details
12.2.2 Company Description and Business Overview
12.2.3 Dental Regenerative Introduction
12.2.4 Dentsply Sirona Revenue in Dental Regenerative Business (2014-2019)
12.2.5 Dentsply Sirona Recent Development
12.3 3M
12.3.1 3M Company Details
12.3.2 Company Description and Business Overview
12.3.3 Dental Regenerative Introduction
12.3.4 3M Revenue in Dental Regenerative Business (2014-2019)
12.3.5 3M Recent Development
12.4 Zimmer Biomet
12.4.1 Zimmer Biomet Company Details
12.4.2 Company Description and Business Overview
12.4.3 Dental Regenerative Introduction
12.4.4 Zimmer Biomet Revenue in Dental Regenerative Business (2014-2019)
12.4.5 Zimmer Biomet Recent Development
12.5 Astellas US Holding
12.5.1 Astellas US Holding Company Details
12.5.2 Company Description and Business Overview
12.5.3 Dental Regenerative Introduction
12.5.4 Astellas US Holding Revenue in Dental Regenerative Business (2014-2019)
12.5.5 Astellas US Holding Recent Development
12.6 Integra LifeSciences
12.6.1 Integra LifeSciences Company Details
12.6.2 Company Description and Business Overview
12.6.3 Dental Regenerative Introduction
12.6.4 Integra LifeSciences Revenue in Dental Regenerative Business (2014-2019)
12.6.5 Integra LifeSciences Recent Development
12.7 Datum Dental
12.7.1 Datum Dental Company Details
12.7.2 Company Description and Business Overview
12.7.3 Dental Regenerative Introduction
12.7.4 Datum Dental Revenue in Dental Regenerative Business (2014-2019)
12.7.5 Datum Dental Recent Development

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)

NORAH TRENT
Wise Guy Reports
841-198-5042
email us here
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}
["facebook", "twitter", "linkedin"]


Source: EIN Presswire

Another Psychiatric Drug, Another Act of Senseless Violence: the All-Too Often Finding in Mass Killings CCHR reports

Of 409 official psychiatric drug agency warnings, 49 warn of suicide or suicidal ideation and 27 warn of violence, hostility, aggression and homicidal ideation.

Photo by Trey Gibson on Unsplash

The Citizens Commission on Human Rights is a non-profit mental health watchdog dedicated to the eradication of abuses committed under the guise of mental health.

The Citizens Commission on Human Rights is a non-profit mental health watchdog dedicated to the eradication of abuses committed under the guise of mental health.

CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections.

CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections.

The Florida chapter of CCHR is a non-profit mental health watchdog dedicated to the protection of children.

The Florida chapter of CCHR is a non-profit mental health watchdog dedicated to the protection of children.

The headquarters for CCHR Florida are located in downtown Clearwater.

The headquarters for CCHR Florida are located in downtown Clearwater.

Of 409 official psychiatric drug agency warnings, 49 warn of suicide or suicidal ideation and 27 warn of violence, hostility, aggression and homicidal ideation.

There is enough evidence to warrant a federal investigation into the link between psychotropic drugs and acts of violence.”

— Jan Eastgate, president of CCHR International

CLEARWATER, FLORIDA, UNITED STATES, September 1, 2019 /EINPresswire.com/ — Montgomery County Coroner has confirmed that the alleged Dayton, Ohio shooter had the benzodiazepine, alprazolam, in his system along with cocaine, alcohol and other substances. [1] In its report, Psychiatric Drugs Create Violence and Suicide, the mental health watchdog Citizens Commission on Human Rights (CCHR) details at least nine other prominent senseless acts of violence since 2008 where the person responsible was taking a benzodiazepine, sometimes with an antidepressant. Of these, four had taken alprazolam. Combined, they were responsible for 260 deaths and about 650 wounded. When taken with other drugs and alcohol, benzodiazepines increase their effects. [2]

According to a forensic study that the U.S. National Institutes of Health posted, benzodiazepines can cause behavioral dis-inhibition, hostility, rage, “serious crimes and sometimes homicides.” Combined with alcohol, they produce “hazardous” states. [3]

Finnish researchers published the findings in their 2015 study that linked tranquilizers, which includes benzodiazepines, to violence. The drugs were found to increase the risk of a consumer committing a homicide by 45% and antidepressant by 31%. [4] A study published in the European Journal of Clinical Pharmacology also found that “…benzodiazepines and [SSRI antidepressants] are the main pharmacological classes able to induce aggressive behavior.’ [5]

A further study published in the Australian and New Zealand Journal of Psychiatry, examined 46 studies on the relationship between benzodiazepines and aggressive behaviors, finding: “An association between benzodiazepine use and subsequent aggressive behavior was found in the majority of the more rigorous studies…” Diazepam and alprazolam received the most attention. [6]

Jan Eastgate, president of CCHR International, said: “There is enough evidence to warrant a federal investigation into the link between psychotropic drugs and acts of violence. Despite investment in violence prevention programs, between 2014 and 2018, at least five acts of senseless violence in schools involving shootings or stabbings have left 21 dead and 22 wounded.”

Federal budgets have allocated millions of dollars to school violence prevention efforts, which include training for school personnel to recognize the signs and symptoms of mental “illness” in students. Mental Health First Aid (MHFA) is one program. [7] Yet a study published in Studies in Social Justice in 2016 said the MHFA “trains citizens to pathologize human suffering” and “produces new, more reachable psychiatric patients, presuming and thereby increasing citizen availability to psychiatric contact and life-long patienthood.” [8]

Developed in Australia, MHFA is overseen in the U.S. by the National Council for Behavioral Health, a group that is funded by at least 12 pharmaceutical companies. Patrick Hahn, a professor of biology at Loyola University said that MHFA is geared toward pushing young people toward more psychiatric drugs, questioning whether parents are aware that the training was “an eight-hour infomercial bought and paid for by the drug makers?” [9]

Several psychiatrists argue there is no “scientific” evidence—clinical trials—that prove psychiatric drugs cause mass shootings. [10] However, clinical trials are unlikely to be approved to deliberately induce violence. Eastgate adds, “Astoundingly, one professor of psychiatry dismissed any drug link, giving an analogy that a mind-altering drug impacting the behavior was as likely as wearing a pair of shoes.” “Why not point to some other ‘factor’ that is common to 100% of mass shooters—wearing shoes, for example,” the psychiatrist said. “Every mass shooter on record was wearing some type of shoes at the time, but it would be absurd to blame shoes for mass shootings."

The psychiatrist’s conflicts of interest include research funds and consulting fees from pharmaceutical companies, Eli Lilly and Novartis and addressing a seminar on violence and mental illness, sponsored by Pfizer—the manufacturer of three antidepressants and the benzodiazepine, Xanax and Xanax XR (alprazolam, extended release). [11] The FDA lists side effects of Xanax XR that include agitation, aggression, anger, homicidal ideation and suicidal ideation. [12]

Further, the false advice given to the White House is that loosening involuntary commitment laws to identify “mentally disturbed individuals” would reduce mass shootings. [13] Diane Stein, president of CCHR Florida points out: “Psychiatrists and psychologists are terrible at predicting a danger to oneself and others—an arbitrary requirement for involuntary commitment.” Accumulated research literature indicates that errors in predicting dangerousness range from 54% to 94%, averaging about 85%. [14] A Wayne State University Law School report states: “For nearly twenty years we have known that psychiatrists cannot predict whether a person who has committed a violent act will be violent in the future.” [15]

“With 29 medical studies and 27 drug regulatory agency warnings showing that psychotropic drug adverse effects include mania, psychosis, hostility, aggression or homicidal ideation, it behooves governments to investigate this,” Eastgate and Stein stated.

They want to see a law enacted similar to a New York Assembly Bill introduced that would require police to report on certain crimes and suicides committed by a person using psychotropic drugs. [16] A report on psychiatric drug usage in such crimes could be made public to identify which drugs are most associated with violence.

About CCHR: Initially established by the Church of Scientology and renowned psychiatrist Dr. Thomas Szasz in 1969, CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. L. Ron Hubbard, founder of Scientology, first brought psychiatric imprisonment to wide public notice: “Thousands and thousands are seized without process of law, every week, over the ‘free world’ tortured, castrated, killed. All in the name of ‘mental health,’” he wrote in March 1969. For more information visit, www.cchrflorida.org

SOURCES:

[1] “Gunman in Dayton mass shooting had cocaine and other substances in his system,” NBC News, 15 Aug. 2019, https://www.nbcnews.com/news/us-news/gunman-dayton-mass-shooting-had-cocaine-other-substances-his-system-n1042906
[2] https://www.rxlist.com/benzodiazepines/drugs-condition.htm ; From CCHR’s report, killers on benzos include: Marine Lance Corporal Delano Holmes), 1 dead; Former U.S. Marine Gavin Long, – 3 dead, 3 wounded; Stephen Paddock Las Vegas, Nevada, 59 dead, 500 wounded; Andreas Lubitz, Southern France (German wings) 150 dead;
Dylann Storm Roof , Lexington, 9 dead; Elliot Rodger, Santa Barbara, California, 2 dead, wounded 1; James Holmes, Aurora, Colorado, 12 dead, 70 wounded; Robert Kenneth Stewart, 8 dead, 3 wounded; Christopher Wood, 4 dead, committed suicide; Steven Kazmierczak, killed 5, 21 wounded; Matti Saari, Kauhajoki, Finland, 10 dead, 1 wounded (2008); Total: 371 dead; 599 wounded
[3] Michel L, Lang JP., “Benzodiazepines and forensic aspects,” Encephale, 2003 Nov-Dec; 29(6):479-85, https://www.ncbi.nlm.nih.gov/pubmed/15029082
[4] David DiSalvo, "Common Painkillers And Sedatives Linked To Increased Risk Of Homicide, According To Study," Forbes, 4 June 2015, https://www.forbes.com/sites/daviddisalvo/2015/06/04/common-pain-killers-and-sedatives-linked-to-increased-risk-of-homicide-according-to-study/#1083a9581aef.
[5] Nadege Rouve, Haleh Bagheri, et al., "Prescribed drugs and violence: a case/noncase study in the French PharmacoVigilance Database,” European Journal of Clinical Pharmacology, 7 June 2011, http://www.ncbi.nlm.nih.gov/pubmed/21655992
[6] Albrecht B, et al., “Benzodiazepine use and aggressive behaviour: A systematic review,” Australian and New Zealand Journal of Psychiatry, 2 Sept. 2014, https://www.ncbi.nlm.nih.gov/books/NBK293296/
[7] “President Trump Releases FY 2020 Budget Proposal,” 15 Mar. 2019,
https://www.thenationalcouncil.org/capitol-connector/2019/03/president-trump-releases-fy-2020-budget-proposal/
[8] Jan Nadine DeFehr, “Inventing Mental Health First Aid: The Problem of Psychocentrism,” Studies in Social Justice, Vol, 10, Issue 1, 2016, http://www.westernmassrlc.org/images/stories/Inventing_Mental_Health_First_Aid_The_Problem_of_P.pdf
[9] “Drug companies prey on children,” The Baltimore Sun, 25 Dec. 2016,
https://www.baltimoresun.com/opinion/op-ed/bs-ed-youth-overmedication-20161225-story.html
[10] “VERIFY: In the past 20 years did the majority of mass shooters take psychotropic drugs before committing a crime?” 13 Aug. 2019,
WUSA9.com, https://www.wusa9.com/article/news/verify-in-the-past-20-years-did-the-majority-of-mass-shooters-take-psychotropic-drugs-before-committing-a-crime/65-60d0c48d-9dab-4129-9176-47d58e4a283a
[11] https://www.fiercepharma.com/sales-and-marketing/pfizer-forest-and-lilly-dominate-top-10-ranking-of-psych-meds ; https://www.pfizer.com/news/press-release/press-release-detail/pfizer_s_pristiq_desvenlafaxine_demonstrates_low_potential_for_sexual_dysfunction_in_adults_with_major_depressive_disorder
[12] https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021434s016lbl.pdf
[13] https://reason.com/2019/08/06/to-stop-mass-shooters-trump-says-we-should-make-involuntary-psychiatric-treatment-easier-no-we-shouldnt/
[14] Margaret Hagen, Whores of the Court, The Fraud of Psychiatric Testimony and the Rape of American Justice, (Harper Collins Publishers, Inc., New York, 1997), p. 165, citing Terrence W. Campbell, “Challenging Psychologists and Psychiatrists as Witnesses,” Michigan Bar Journal, Jan. 1994.
[15] Erica Beecher-Monas , Edgar Garcia-Ril, “Danger at the Edge of Chaos: Predicting Violent Behavior in a Post-Daubert World,” Law Faculty Research Publications, 1-1-2003, https://pdfs.semanticscholar.org/e1fe/bb1382d282dde06cc3e3707c2ffecab9c8ce.pdf
[16] https://www.cchrint.org/nybillpsychiatricdruguse/

Diane Stein
Citizens Commission on Human Rights of Florida
(727) 422-8820
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

School Shootings & Psychiatric Drugs—Constitutional Attorney Jonathan Emord


Source: EIN Presswire